Ardevora Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$17.1M Sell
157,288
-119,118
-43% -$12.4M 1.53% 10
2023
Q3
$28.5M Sell
276,406
-193,335
-41% -$20.8M 1.4% 21
2023
Q2
$54.2M Buy
469,741
+178,700
+61% +$20.3M 1.31% 23
2023
Q1
$31M Sell
291,041
-247,300
-46% -$26.7M 0.56% 73
2022
Q4
$59.7M Sell
538,341
-61,359
-10% -$6.27M 1.02% 34
2022
Q3
$51.6M Sell
599,700
-9,400
-2% -$839K 0.93% 34
2022
Q2
$55.5M Buy
+609,100
New +$54M 0.91% 32

Other funds holding MRK

Ardevora Asset Management's MRK Position: Q4 2023 in Review

Ardevora Asset Management reduced its Merck (MRK) stake by 43% in Q4 2023, selling an estimated $12.4M and leaving 157,288 shares worth $17.1M. The position accounts for 1.53% of the portfolio, ranked #10.

Ardevora Asset Management first reported a position in MRK in Q2 2022 and has held it in 7 quarters since. The position peaked at $59.7M in Q4 2022. 3,434 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Ardevora Asset Management held 157,288 shares of Merck worth $17.1M as of Q4 2023.
  • Ardevora Asset Management sold 119,118 Merck shares in Q4 2023, an estimated $12.4M.
  • Merck made up 1.53% of Ardevora Asset Management's portfolio in Q4 2023, its #10 holding.
  • Ardevora Asset Management first reported a position in Merck in Q2 2022 and has held it in 7 quarters since.
  • Ardevora Asset Management's Merck position peaked at $59.7M in Q4 2022.
  • 3,434 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Ardevora Asset Management's 13F filing for Q4 2023, filed 1 Feb 2024.